Salarius Pharmaceuticals Inc (FRA:FP10)
€ 3.008 0 (0%) Market Cap: 2.31 Mil Enterprise Value: -526,000.00 PE Ratio: 0 PB Ratio: 0.82 GF Score: 29/100

Q2 2020 Salarius Pharmaceuticals Inc Earnings Call Transcript

Aug 12, 2020 / 08:30PM GMT
Release Date Price: €171 (-11.40%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Salarius Pharmaceutical earnings webcast and conference call. (Operator Instructions)

I would now like to hand the conference over to your host for today, Greg Tiberend of Tiberend Strategic Advisors. Thank you. Please go ahead.

Gregory Tiberend;Tiberend Strategic Advisors
Inc.,

Thank you, Kelsey. Good afternoon, everyone, and thank you for joining today's 2020 second quarter financial and corporate results call.

Earlier this afternoon, Salarius Pharmaceuticals issued a press release, detailing its financial results for the 3 months ended June 30, 2020, which we encourage listeners to read. The press release can be found in the News section of salariuspharma.com, their website. It's also -- Salarius also filed the 10-Q this afternoon, which is available also on their website and at sec.gov.

Today, we will be making certain forward-looking statements about future expectations, plans, events and circumstances, including statements about our strategy,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot